We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+3.04%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$995M
AUM Growth
+$63.9M
Cap. Flow
+$40.8M
Cap. Flow %
4.1%
Top 10 Hldgs %
15.14%
Holding
1,060
New
134
Increased
450
Reduced
317
Closed
75

Sector Composition

Rank Sector Weight
1 Technology 12.73%
2 Financials 9.55%
3 Healthcare 8.91%
4 Consumer Discretionary 8.6%
5 Industrials 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASX icon
901
ASE Group
ASX
$80.8B
$73K 0.01%
+18,428
New +$77K
DSE
902
DELISTED
Duff & Phelps Select MLP and Midstream Energy Fund Inc.
DSE
$70K 0.01%
1,433
-80
-5% -$3.98K
SITO
903
DELISTED
SITO MOBILE, LTD
SITO
$70K 0.01%
89,105
-57,400
-39% -$79K
CBB
904
DELISTED
Cincinnati Bell Inc.
CBB
$70K 0.01%
+14,100
New +$108K
ZSAN
905
DELISTED
Zosano Pharma Corporation
ZSAN
$68K 0.01%
+596
New +$70.5K
CXE
906
DELISTED
MFS High Income Municipal Trust
CXE
$67K 0.01%
12,838
SIRI icon
907
SiriusXM
SIRI
$10B
$63K 0.01%
+1,123
New +$63.9K
ALNA
908
DELISTED
Allena Pharmaceuticals
ALNA
$63K 0.01%
+15,400
New +$84.1K
NCV
909
Virtus Convertible & Income Fund
NCV
$374M
$62K 0.01%
+2,729
New +$63.2K
NSL
910
DELISTED
NUVEEN SENIOR INCM FD
NSL
$62K 0.01%
10,395
BYFC icon
911
Broadway Financial
BYFC
$94.9M
$61K 0.01%
5,348
-8,454
-61% -$91.2K
STON
912
DELISTED
StoneMor Inc.
STON
$61K 0.01%
27,770
MMT
913
Aberdeen Multi-Market Income Fund
MMT
$237M
$60K 0.01%
10,352
+41
+0.4% +$234
CLSD
914
DELISTED
Clearside Biomedical
CLSD
$59K 0.01%
4,067
-33
-0.8% -$589
QNRX
915
Quoin Pharmaceuticals
QNRX
$8.6M
$59K 0.01%
1
DMK
916
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$58K 0.01%
637
+371
+139% +$45.1K
AMPE
917
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$58K 0.01%
496
-593
-54% -$93.9K
NAVB
918
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$56K 0.01%
89,208
+74,258
+497% +$144K
GASS icon
919
StealthGas
GASS
$328M
$55K 0.01%
15,850
-1,994
-11% -$6.74K
TOVX icon
920
Theriva Biologics
TOVX
$10.2M
$54K 0.01%
+392
New +$56.4K
AKBA icon
921
Akebia Therapeutics
AKBA
$327M
$52K 0.01%
+10,800
New +$61.4K
HCR
922
DELISTED
Hi-Crush Inc. Common Stock
HCR
$51K 0.01%
20,695
-2,531
-11% -$7.91K
NBEV
923
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$50K 0.01%
10,700
-6,850
-39% -$35.1K
AUY
924
DELISTED
Yamana Gold, Inc.
AUY
$49K ﹤0.01%
19,479
+5
+0% +$11
CCM
925
Concord Medical Services
CCM
$18.7M
$48K ﹤0.01%
2,122
-21
-1% -$514

Similar funds

Wedbush Securities's Q2 2019 Portfolio in Review

As of Q2 2019, Wedbush Securities held 1,060 positions worth $995M, up 6.9% from $931M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Wedbush Securities deployed $40.8M of net new capital in Q2 2019, opening 134 new positions and adding to 450 existing holdings. Its largest new stake was Pacer WealthShield ETF: 48,221 shares worth $1.17M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was PAR Technology, an estimated $1.67M trimmed.

  • Wedbush Securities's largest Q2 2019 buy was Pacer WealthShield ETF: 48,221 shares worth $1.17M.
  • Wedbush Securities added most to Walt Disney in Q2 2019, an estimated $1.72M increase.
  • Wedbush Securities's biggest Q2 2019 reduction was PAR Technology, cutting an estimated $1.67M.
  • Wedbush Securities fully exited PIMCO Active Bond Exchange-Traded Fund in Q2 2019, selling an estimated $1.08M.
  • Wedbush Securities's ten largest holdings make up 15% of its $995M portfolio in Q2 2019.
  • Wedbush Securities opened 134 new positions and closed 75 in Q2 2019.
  • Wedbush Securities's portfolio value rose 6.9% quarter-over-quarter to $995M.

Based on Wedbush Securities's 13F filing for Q2 2019, filed 1 Aug 2019.